Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.85 Analyst target: $490.00 Upside: 26386.49%
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company is headquartered in Palo Alto, California.
See the full interactive analysis & chart →Informational only — not investment advice.